PT  - JOURNAL ARTICLE
AU  - Shruti Agrawal
AU  - Michael Leonard Anthony
AU  - Pranoy Pal
AU  - Divya Singh
AU  - Anoushika Mehan
AU  - Ashok Singh
AU  - Prashant Joshi
AU  - Arvind Kumar
AU  - Bina Ravi
AU  - Shalinee Rao
AU  - Nilotpal Chowdhury
TI  - Prospective evaluation of accuracy of fine needle aspiration biopsy for breast lesions using the International Academy of Cytology Yokohama System for reporting breast cytopathology
AID  - 10.1101/2020.12.21.20248687
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.12.21.20248687
4099  - http://medrxiv.org/content/early/2020/12/22/2020.12.21.20248687.short
4100  - http://medrxiv.org/content/early/2020/12/22/2020.12.21.20248687.full
AB  - Background Classification of breast leasions into different cytological groups (1-5) can accurately be done using the International Academy of Cytology (IAC) Yokohama System for reporting breast cytopathology. Fine needle aspiration biopsy (FNAB) of breast leasions has been considered to be the primary investigation in detecting breast cancers, especially in low-cost settings. The main objective of this study was to prospectively re-confirm the diagnostic accuracy of breast FNAB using the IAC Yokohama system. Additionally, separate separate secondary subgroup analysis was done to confirm the accuracy of breast FNAB excluding lymph-node positive and lymphadenopathy positive tumors.Material and methods A prospective study was done in a tertiary care centre in North India on patients undergoing core-needle /incisional/excisional biopsy of breast lesions between 1st September 2019 to 30th November,2020 (519 biopsies on 487 unique patients). Of these 519 histopathology biopsies, 505 had corresponding FNAB report of the same site. The FNAB was reported using the IAC Yokohama system and the most suitable category was allotted in every case. The rates of malignancy for each category and the accuracy of breast FNAB in diagnosing malignancy were calculated.Results Of the total 487 patients, 120 cases were benign on histology, while 367 were malignant. The rates of malignancy in benign, atypical, suspicious and malignant categories were 5%, 25%, 71% and 99.7% respectively. The diagnostic accuracy of atypical, suspicious and malignant categories was calculated as 90.1%, 95.2% and 93.3% respectively.Conclusion The high sensitivity and specificity for each scenario for all tumors and for each examined BIRADS category/ies suggest excellent accuracy for Breast FNAB using the IAC Yokohama system.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional Ethical Committee, AIIMS RishikeshAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data used in the study has been provided in the manjscript and as supplementary files.